As of Jun 24
| +0.02 / +1.49%|
The 1 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +47.06% increase from the last price of 1.36.
The current consensus among 2 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.